Published in Nat Chem Biol on December 25, 2011
In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer. Nat Med (2014) 2.68
A public-private partnership to unlock the untargeted kinome. Nat Chem Biol (2013) 1.83
IL-13-induced airway mucus production is attenuated by MAPK13 inhibition. J Clin Invest (2012) 1.29
Mechanism and consequence of the autoactivation of p38α mitogen-activated protein kinase promoted by TAB1. Nat Struct Mol Biol (2013) 1.01
The ins and outs of selective kinase inhibitor development. Nat Chem Biol (2015) 0.98
Arachidonoyl-phosphatidylcholine oscillates during the cell cycle and counteracts proliferation by suppressing Akt membrane binding. Proc Natl Acad Sci U S A (2013) 0.90
The crystal structure of phosphorylated MAPK13 reveals common structural features and differences in p38 MAPK family activation. Acta Crystallogr D Biol Crystallogr (2015) 0.78
Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6. Springerplus (2016) 0.76
Microtubules Inhibit E-Cadherin Adhesive Activity by Maintaining Phosphorylated p120-Catenin in a Colon Carcinoma Cell Model. PLoS One (2016) 0.76
C3 exoenzyme impairs cell proliferation and apoptosis by altering the activity of transcription factors. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.75
Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound-Kinase Activities: A Way toward Selective Promiscuity by Design? J Chem Inf Model (2016) 0.75
First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes. Biochim Biophys Acta (2016) 0.75
The protein kinase complement of the human genome. Science (2002) 35.36
A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol (2008) 14.74
Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer (2009) 9.33
The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis. Ann Rheum Dis (2007) 1.63
MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38alpha protein. Curr Med Chem (2005) 1.47
Design, synthesis, and biological evaluation of phenylamino-substituted 6,11-dihydro-dibenzo[b,e]oxepin-11-ones and dibenzo[a,d]cycloheptan-5-ones: novel p38 MAP kinase inhibitors. J Med Chem (2006) 1.39
Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10. J Virol (2002) 1.34
The p38alpha kinase plays a central role in inflammation. Curr Top Med Chem (2009) 1.30
Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A. J Biol Chem (2009) 1.25
Rho kinase-2 activation in human endothelial cells drives lysophosphatidic acid-mediated expression of cell adhesion molecules via NF-kappaB p65. J Biol Chem (2010) 1.22
Structural basis for p38alpha MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity. Nat Struct Biol (2003) 1.16
Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity. J Pharmacol Exp Ther (2008) 1.03
Pathway to the clinic: inhibition of P38 MAP kinase. A review of ten chemotypes selected for development. Curr Top Med Chem (2005) 1.02
Macrophage migration inhibitory factor elicits an angiogenic phenotype in human ectopic endometrial cells and triggers the production of major angiogenic factors via CD44, CD74, and MAPK signaling pathways. J Clin Endocrinol Metab (2010) 0.96
Interleukin-3, -5, and granulocyte macrophage colony-stimulating factor induce adhesion and chemotaxis of human eosinophils via p38 mitogen-activated protein kinase and nuclear factor kappaB. Immunopharmacol Immunotoxicol (2005) 0.94
The Mycobacterium tuberculosis early secreted antigenic target of 6 kDa inhibits T cell interferon-γ production through the p38 mitogen-activated protein kinase pathway. J Biol Chem (2011) 0.93
Successful structure-based design of recent p38 MAP kinase inhibitors. Curr Top Med Chem (2009) 0.93
Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an orally bioavailable and highly selective inhibitor of p38 MAP kinase. J Med Chem (2006) 0.89
αVβ3-integrin expression through ERK activation mediates cell attachment and is necessary for production of tumor necrosis factor alpha in monocytic THP-1 cells stimulated by phorbol myristate acetate. Cell Immunol (2011) 0.87
Glycogen synthase kinase-3 and p38 MAPK are required for opioid-induced microglia apoptosis. Neuropharmacology (2010) 0.84
The p38 mitogen-activated protein kinase pathway plays a critical role in PAR2-induced endothelial IL-8 production and leukocyte adhesion. Shock (2008) 0.81
Hyperosmolar sodium chloride, p38 mitogen activated protein and cytokine-mediated inflammation. Semin Dial (2009) 0.78
Aza-analogue dibenzepinone scaffolds as p38 mitogen-activated protein kinase inhibitors: design, synthesis, and biological data of inhibitors with improved physicochemical properties. J Med Chem (2009) 0.78
Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science (2002) 7.87
Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Sci Transl Med (2010) 6.39
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet (2012) 5.28
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. J Clin Invest (2009) 5.07
Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discov (2011) 4.80
Solitary fibrous tumors of the pleura. Ann Thorac Surg (2002) 4.78
Eater, a transmembrane protein mediating phagocytosis of bacterial pathogens in Drosophila. Cell (2005) 3.22
Transition networks for modeling the kinetics of conformational change in macromolecules. Curr Opin Struct Biol (2008) 3.03
Gangliosides are receptors for murine polyoma virus and SV40. EMBO J (2003) 2.99
Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancer. Proc Natl Acad Sci U S A (2009) 2.77
In vivo protein crystallization opens new routes in structural biology. Nat Methods (2012) 2.69
5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem Sci (2007) 2.53
Structure-guided development of affinity probes for tyrosine kinases using chemical genetics. Nat Chem Biol (2007) 2.43
Small-molecule inhibition of APT1 affects Ras localization and signaling. Nat Chem Biol (2010) 2.37
Structural basis of GM1 ganglioside recognition by simian virus 40. Proc Natl Acad Sci U S A (2008) 2.37
Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass? J Thorac Cardiovasc Surg (2003) 2.14
An unbiased cell morphology-based screen for new, biologically active small molecules. PLoS Biol (2005) 2.11
Crystal structure of reovirus attachment protein sigma1 reveals evolutionary relationship to adenovirus fiber. EMBO J (2002) 2.06
Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant (2008) 1.77
Tropomyosin position on F-actin revealed by EM reconstruction and computational chemistry. Biophys J (2011) 1.76
The shape and flexibility of tropomyosin coiled coils: implications for actin filament assembly and regulation. J Mol Biol (2009) 1.75
Neuroendocrine carcinoma (carcinoid) of the thymus associated with Cushing's syndrome. Ann Thorac Surg (2002) 1.74
Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. J Clin Invest (2009) 1.73
Health and lifestyle in rural northeast Germany: the findings of a Rural Health Study from 1973, 1994, and 2008. Dtsch Arztebl Int (2012) 1.70
Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med (2002) 1.69
2-Acylaminopyridin-4-ylimidazoles as p38 MAP kinase inhibitors: Design, synthesis, and biological and metabolic evaluations. ChemMedChem (2009) 1.69
Does the integrin alphaA domain act as a ligand for its betaA domain? Curr Biol (2002) 1.69
A novel adaptation of the integrin PSI domain revealed from its crystal structure. J Biol Chem (2004) 1.68
The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis. Nat Med (2010) 1.63
Structure-function analysis of the human JC polyomavirus establishes the LSTc pentasaccharide as a functional receptor motif. Cell Host Microbe (2010) 1.60
Long-term outcome after pulmonary retransplantation. J Thorac Cardiovasc Surg (2006) 1.59
Structure of the measles virus hemagglutinin bound to the CD46 receptor. Nat Struct Mol Biol (2009) 1.58
Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding. Proc Natl Acad Sci U S A (2003) 1.57
Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia (2008) 1.57
Interactive exploration of chemical space with Scaffold Hunter. Nat Chem Biol (2009) 1.55
Role of the hydrogen bonding heteroatom-Lys53 interaction between the p38alpha mitogen-activated protein (MAP) kinase and pyridinyl-substituted 5-membered heterocyclic ring inhibitors. J Med Chem (2009) 1.55
Strategies for the selective regulation of kinases with allosteric modulators: exploiting exclusive structural features. ACS Chem Biol (2012) 1.55
Tri- and tetrasubstituted pyrazole derivates: regioisomerism switches activity from p38MAP kinase to important cancer kinases. J Med Chem (2012) 1.52
Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative? Eur J Cardiothorac Surg (2002) 1.49
The structure of dimethylallyl tryptophan synthase reveals a common architecture of aromatic prenyltransferases in fungi and bacteria. Proc Natl Acad Sci U S A (2009) 1.48
Thrombus formation in a HeartMate II left ventricular assist device. J Thorac Cardiovasc Surg (2008) 1.46
New insights into the structural basis of integrin activation. Blood (2003) 1.45
ALOX5 variants associated with susceptibility to human pulmonary tuberculosis. Hum Mol Genet (2008) 1.43
Junctional adhesion molecule a serves as a receptor for prototype and field-isolate strains of mammalian reovirus. J Virol (2005) 1.43
Chemogenomic profiling provides insights into the limited activity of irreversible EGFR Inhibitors in tumor cells expressing the T790M EGFR resistance mutation. Cancer Res (2010) 1.43
Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer. J Clin Invest (2013) 1.41
Adenovirus type 11 binding alters the conformation of its receptor CD46. Nat Struct Mol Biol (2007) 1.41
Human carbonyl reductase 1 is an S-nitrosoglutathione reductase. J Biol Chem (2008) 1.40
New nickel(II) diimine complexes and the control of polyethylene microstructure by catalyst design. J Am Chem Soc (2007) 1.40
ALK mutations conferring differential resistance to structurally diverse ALK inhibitors. Clin Cancer Res (2011) 1.40
Clinical relevance of intracranial high intensity transient signals in patients following prosthetic aortic valve replacement. Eur J Cardiothorac Surg (2002) 1.38
The mechanism of the reverse recovery step, phosphate release, and actin activation of Dictyostelium myosin II. J Biol Chem (2008) 1.37
Dynamic interaction of the measles virus hemagglutinin with its receptor signaling lymphocytic activation molecule (SLAM, CD150). J Biol Chem (2008) 1.29
Distinct kinetics for binding of the CD46 and SLAM receptors to overlapping sites in the measles virus hemagglutinin protein. J Biol Chem (2002) 1.28
ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma. Proc Natl Acad Sci U S A (2008) 1.28
Identification of CD46 binding sites within the adenovirus serotype 35 fiber knob. J Virol (2007) 1.27
The relationship between curvature, flexibility and persistence length in the tropomyosin coiled-coil. J Struct Biol (2010) 1.27
TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine (2008) 1.26
Structure of reovirus sigma1 in complex with its receptor junctional adhesion molecule-A. PLoS Pathog (2008) 1.25
Health-related quality of life in two hundred-eighty lung transplant recipients. J Heart Lung Transplant (2005) 1.25
Oxidizable residues mediating protein stability and cytoprotective interaction of DJ-1 with apoptosis signal-regulating kinase 1. J Biol Chem (2009) 1.24
Arylpyrrolizines as inhibitors of microsomal prostaglandin E2 synthase-1 (mPGES-1) or as dual inhibitors of mPGES-1 and 5-lipoxygenase (5-LOX). J Med Chem (2009) 1.23
The 5-lipoxygenase promoter is regulated by DNA methylation. J Biol Chem (2001) 1.22
The structural coupling between ATPase activation and recovery stroke in the myosin II motor. Structure (2007) 1.22
Transcriptome and functional analysis of the eukaryotic-type serine/threonine kinase PknB in Staphylococcus aureus. J Bacteriol (2009) 1.22
Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc. J Med Chem (2009) 1.21
Can the calculation of ligand binding free energies be improved with continuum solvent electrostatics and an ideal-gas entropy correction? J Comput Chem (2002) 1.21
Viruses and sialic acids: rules of engagement. Curr Opin Struct Biol (2011) 1.21
A framework for identification of actionable cancer genome dependencies in small cell lung cancer. Proc Natl Acad Sci U S A (2012) 1.21
Thymomas: review of current clinical practice. Ann Thorac Surg (2009) 1.21
Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens. PLoS Pathog (2010) 1.20
Structural basis of cell wall cleavage by a staphylococcal autolysin. PLoS Pathog (2010) 1.20
Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes. J Neurosci (2006) 1.20
Highly enantioselective synthesis and cellular evaluation of spirooxindoles inspired by natural products. Nat Chem (2010) 1.19
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer. Cancer Discov (2013) 1.18
Mechanism of primary proton transfer in bacteriorhodopsin. Structure (2004) 1.17
Natural-product-derived fragments for fragment-based ligand discovery. Nat Chem (2012) 1.17
Crystal structure of reovirus attachment protein σ1 in complex with sialylated oligosaccharides. PLoS Pathog (2011) 1.17
The therapeutic potential of phosphatase inhibitors. Curr Opin Chem Biol (2009) 1.16
Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors. J Med Chem (2005) 1.16
A new screening assay for allosteric inhibitors of cSrc. Nat Chem Biol (2009) 1.16
Structure-function analysis of reovirus binding to junctional adhesion molecule 1. Implications for the mechanism of reovirus attachment. J Biol Chem (2003) 1.16
The Polyomaviridae: Contributions of virus structure to our understanding of virus receptors and infectious entry. Virology (2009) 1.15
Carnosic acid and carnosol potently inhibit human 5-lipoxygenase and suppress pro-inflammatory responses of stimulated human polymorphonuclear leukocytes. Biochem Pharmacol (2008) 1.14
Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. Biochem Pharmacol (2002) 1.13
Automated computation of low-energy pathways for complex rearrangements in proteins: application to the conformational switch of Ras p21. Proteins (2005) 1.12
Sleep's function in the spontaneous recovery and consolidation of memories. J Exp Psychol Gen (2007) 1.12
Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data. Clin Pharmacokinet (2011) 1.12
The flexibility of two tropomyosin mutants, D175N and E180G, that cause hypertrophic cardiomyopathy. Biochem Biophys Res Commun (2012) 1.12
Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production. Proc Natl Acad Sci U S A (2006) 1.12